Development of mucus-penetrating antibiotic and quorum sensing inhibitor nanoparticle complex for bronchiectasis therapy
Bronchiectasis is a chronic respiratory disease characterized by permanent and irreversible dilatation of the airways caused by a vicious cycle of infection and inflammation, leading to the loss of lung function, morbidity, and mortality. Early results suggested inhaled ciprofloxacin (CIP) as a prom...
Saved in:
Main Author: | Tran, The Thien |
---|---|
Other Authors: | Kunn Hadinoto Ong |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/145374 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
A potential quorum-sensing inhibitor for bronchiectasis therapy: quercetin–chitosan nanoparticle complex exhibiting superior inhibition of biofilm formation and swimming motility of Pseudomonas aeruginosa to the native quercetin
by: Tran, The-Thien, et al.
Published: (2021) -
Ternary nanoparticle complex of antibiotic, polyelectrolyte, and mucolytic enzyme as a potential antibiotic delivery system in bronchiectasis therapy
by: Tran, The-Thien, et al.
Published: (2022) -
Development of inhalable antimicrobial nanoparticle complex
by: Yu, Hong
Published: (2018) -
An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis
by: Tran, The-Thien, et al.
Published: (2020) -
Engineered antibiotic nanoparticles for inhaled anti-biofilm therapy
by: Cheow, Wean Sin
Published: (2012)